These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23375228)

  • 21. Application of human FcRn transgenic mice as a pharmacokinetic screening tool of monoclonal antibody.
    Haraya K; Tachibana T; Nanami M; Ishigai M
    Xenobiotica; 2014 Dec; 44(12):1127-34. PubMed ID: 25030041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple roles for the major histocompatibility complex class I- related receptor FcRn.
    Ghetie V; Ward ES
    Annu Rev Immunol; 2000; 18():739-66. PubMed ID: 10837074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies.
    Wang W; Vlasak J; Li Y; Pristatsky P; Fang Y; Pittman T; Roman J; Wang Y; Prueksaritanont T; Ionescu R
    Mol Immunol; 2011 Mar; 48(6-7):860-6. PubMed ID: 21256596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonclassical major histocompatibility complex I-like Fc neonatal receptor (FcRn) expression in neonatal human tissues.
    Cianga C; Cianga P; Plamadeala P; Amalinei C
    Hum Immunol; 2011 Dec; 72(12):1176-87. PubMed ID: 21978715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Neonatal Fc Receptor (FcRn): A Misnomer?
    Pyzik M; Sand KMK; Hubbard JJ; Andersen JT; Sandlie I; Blumberg RS
    Front Immunol; 2019; 10():1540. PubMed ID: 31354709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of the human neonatal Fc-receptor alpha-chain in trophoblast-derived BeWo cells increases cellular retention of beta2-microglobulin.
    Ellinger I; Reischer H; Lehner C; Leitner K; Hunziker W; Fuchs R
    Placenta; 2005; 26(2-3):171-82. PubMed ID: 15708118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal Fc receptor and IgG-based therapeutics.
    Kuo TT; Aveson VG
    MAbs; 2011; 3(5):422-30. PubMed ID: 22048693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal Fc receptor in human immunity: Function and role in therapeutic intervention.
    Patel DD; Bussel JB
    J Allergy Clin Immunol; 2020 Sep; 146(3):467-478. PubMed ID: 32896307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn.
    Kim JK; Firan M; Radu CG; Kim CH; Ghetie V; Ward ES
    Eur J Immunol; 1999 Sep; 29(9):2819-25. PubMed ID: 10508256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of a double transgenic humanized neonatal Fc receptor (FcRn)/albumin mouse to study the pharmacokinetics of albumin-linked drugs.
    Viuff D; Antunes F; Evans L; Cameron J; Dyrnesli H; Thue Ravn B; Stougaard M; Thiam K; Andersen B; Kjærulff S; Howard KA
    J Control Release; 2016 Feb; 223():22-30. PubMed ID: 26699424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of the complex of rat neonatal Fc receptor with Fc.
    Burmeister WP; Huber AH; Bjorkman PJ
    Nature; 1994 Nov; 372(6504):379-83. PubMed ID: 7969498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Translation: FcRn across the Therapeutic Spectrum.
    Qi T; Cao Y
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport.
    Leach JL; Sedmak DD; Osborne JM; Rahill B; Lairmore MD; Anderson CL
    J Immunol; 1996 Oct; 157(8):3317-22. PubMed ID: 8871627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering human IgG1 affinity to human neonatal Fc receptor: impact of affinity improvement on pharmacokinetics in primates.
    Yeung YA; Leabman MK; Marvin JS; Qiu J; Adams CW; Lien S; Starovasnik MA; Lowman HB
    J Immunol; 2009 Jun; 182(12):7663-71. PubMed ID: 19494290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta 2-microglobulin deficient mice catabolize IgG more rapidly than FcRn- alpha-chain deficient mice.
    Kim J; Bronson CL; Wani MA; Oberyszyn TM; Mohanty S; Chaudhury C; Hayton WL; Robinson JM; Anderson CL
    Exp Biol Med (Maywood); 2008 May; 233(5):603-9. PubMed ID: 18375831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative methods for developing Fc mutants with extended half-lives.
    Kamei DT; Lao BJ; Ricci MS; Deshpande R; Xu H; Tidor B; Lauffenburger DA
    Biotechnol Bioeng; 2005 Dec; 92(6):748-60. PubMed ID: 16136591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neonatal Fc receptor, key control of immunoglobulins biodistribution].
    Magdelaine-Beuzelin C; Ohresser M; Watier H
    Med Sci (Paris); 2009 Dec; 25(12):1053-6. PubMed ID: 20035678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.
    Lu Y; Vernes JM; Chiang N; Ou Q; Ding J; Adams C; Hong K; Truong BT; Ng D; Shen A; Nakamura G; Gong Q; Presta LG; Beresini M; Kelley B; Lowman H; Wong WL; Meng YG
    J Immunol Methods; 2011 Feb; 365(1-2):132-41. PubMed ID: 21185301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fc Engineering: Tailored Synthetic Human IgG1-Fc Repertoire for High-Affinity Interaction with FcRn at pH 6.0.
    Saxena A; Bai B; Hou SC; Jiang L; Ying T; Miersch S; Sidhu SS; Wu D
    Methods Mol Biol; 2018; 1827():399-417. PubMed ID: 30196509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting FcRn for the modulation of antibody dynamics.
    Ward ES; Devanaboyina SC; Ober RJ
    Mol Immunol; 2015 Oct; 67(2 Pt A):131-41. PubMed ID: 25766596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.